LIN
LONGINSIDER SELLCONGRESS SELLLinde Plc
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.
News Summary
NeutralLinde delivered record Q2 sales of $9.3B with 10% EPS growth, but operating margins contracted 60bps YoY to 29.5% due to U.S. home care (Lincare) headwinds and lower-margin equipment sales, prompting management to explore strategic alternatives including a potential sale. The company secured a landmark $1B semiconductor supply contract in Phoenix and raised full-year guidance to $17.70–$17.90, though Q3 EPS guidance of $4.45–$4.55 fell below the $4.59 analyst consensus, signaling near-term margin recovery challenges despite strong long-term project backlog.
Red flags
- •Operating margin compression of 60bps YoY in Q2 2026 to 29.5%, with management acknowledging Lincare profitability is unsatisfactory
- •Q3 2026 EPS guidance ($4.45–$4.55) missed consensus estimate ($4.59) despite full-year guidance raise
- •Lincare strategic review including potential sale indicates core business portfolio concerns amid labor cost inflation and reimbursement pressures
- •Stock fell ~5.9% post-Q2 earnings despite record sales, reflecting investor concern over margin trajectory
Funds Buying (4)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Maverick Capital | Lee Ainslie | 426K | +426K | $211M | 2.5% | — | NEW |
| Soros Fund Management | Soros Family Office | 260K | +260K | $129M | 1.8% | — | NEW |
| Point72 | Steve Cohen | 89K | +89K | $44M | <0.1% | — | NEW |
| Duquesne Family Office | Stanley Druckenmiller | 41K | +41K | $20M | 0.7% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where LIN ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #6 of this fund's book
- 3NVIDIA CORPORATION$187M
- 4TAIWAN SEMICONDUCTOR MANUFAC$177M
- 5ALPHABET INC$165M
- 6LINDE PLC$129M
- 7APPLE INC$127M
- 8TKO GROUP HOLDINGS INC$122M
- 9SEALED AIR CORP NEW$116M
position #16 of this fund's book
- 13VISA INC$244M
- 14NATERA INC$234M
- 15CAPITAL ONE FINL CORP$228M
- 16LINDE PLC$211M
- 17DICKS SPORTING GOODS INC$207M
- 18INFLEQTION INC$196M
- 19SOUTHWEST GAS HLDGS INC$185M
position #32 of this fund's book
- 29Jabil Inc$22M
- 30Southern Copper Corp$21M
- 31Ishares S&P Gsci Commodity-$21M
- 32Linde Plc$20M
- 33Seagate Technology Hldngs Pl$20M
- 34Cleveland-Cliffs Inc New$20M
- 35Nuvation Bio Inc$19M
Values are quarter-end position sizes. Shown only for funds where LIN ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Signal History
Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.
Insider Activity
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | SELL | $15,001 - $50,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Jan 1, 2026.